1. 1.60 Autoantibodies to human citrullinated fibrinogen (AhFibA) and their subfamilies directed to the fibrin peptides α36-50Cit38, 42 and β60-7460, 72, 74 are prognostic markers of radiographic damage in the very early arthritides of the French ESPOIR cohort. (31st January 2014) Authors: Cornillet, M; Ruyssen-Witrand, A; Constantin, A; Meyer, O; Cantagrel, A; Serre, G; Nogueira, L; Nogueira, L; Nogueira, L Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 1(2014) Page Start: A26 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A5.7 Autoantibodies to the Fibrin-Derived Citrullinated Peptides α36–50 and β60–74 are Two Distinct Non-Overlapping Subfamilies of ACPA that together almost Summarise their Reactivity to Citrullinated Fibrinogen and to CCP2 Antigens. (25th February 2013) Authors: Cornillet, M; Sebbag, M; Verrouil, E; Magyar, A; Ruyssen-Witrand, A; Hudecz, F; Cantagrel, A; Serre, G; Nogueira, L Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 1(2013) Page Start: A32 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. AB0703 Impact of ANTI-TNF agents on patient-reported outcomes in spondyloarthritis: a systematic review of the literature and meta-analysis. (15th June 2017) Authors: Laclau, S; Constantin, A; Cantagrel, A; Barnetche, T; Ruyssen-Witrand, A; Degboe, Y Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 1299 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Efficacy of tumour necrosis factor blockers in reducing uveitis flares in patients with spondylarthropathy: a retrospective study. Issue 12 (10th August 2006) Authors: Guignard, S; Gossec, L; Salliot, C; Ruyssen-Witrand, A; Luc, M; Duclos, M; Dougados, M Journal: Annals of the rheumatic diseases Issue: Volume 65:Issue 12(2006) Page Start: 1631 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Fcγ receptor type IIIA polymorphism influences treatment outcomes in patients with rheumatoid arthritis treated with rituximab. Issue 6 (25th February 2012) Authors: Ruyssen-Witrand, A; Rouanet, S; Combe, B; Dougados, M; Le Loët, X; Sibilia, J; Tebib, J; Mariette, X; Constantin, A Journal: Annals of the rheumatic diseases Issue: Volume 71:Issue 6(2012) Page Start: 875 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. FRI0234 Choice of biologic therapy following rituximab: influencing factors in a french multicenter cohort of rheumatoid arthritis. (15th June 2017) Authors: Vial, G; Pouilly, A De; Scouppe, L; Pereira, B; Lukas, C; Daien, C; Ruyssen-Witrand, A; Vergne-Salle, P; Tournadre, A; Richez, C Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 573 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. OP0242 Health-related quality of life improved only slightly although disease activity decreased over 3 years in early axial spondyloarthritis: 442 patients from the desir cohort. (15th June 2017) Authors: Puyraimond-Zemmour, D; Desthieux, C; Ruyssen-Witrand, A; Fautrel, B; Gossec, L Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 155 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. SAT0112 Prevalence and incidence over 3 years of different comorbidities in rheumatoid arthritis (RA): a 3 year longitudinal study in 769 established ra patients. (15th June 2017) Authors: Gossec, L; Soubrier, M; Foissac, F; Fayet, F; Balandraud, N; Bardin, T; Beauvais, C; Chales, G; Chary-Valckenaere, I; Dernis, E; Euller-Ziegler, L; Flipo, R-M; Gilson, M; Marhadour, T; Mariette, X; Mouterde, G; Pouplin, S; Richette, P; Ruyssen-Witrand, A; Schaeverbeke, T Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 811 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. The fibrin-derived citrullinated peptide β60–74Cit60, 72, 74 bears the major ACPA epitope recognised by the rheumatoid arthritis-specific anticitrullinated fibrinogen autoantibodies and anti-CCP2 antibodies. Issue 6 (1st May 2013) Authors: Cornillet, M; Sebbag, M; Verrouil, E; Magyar, A; Babos, F; Ruyssen-Witrand, A; Hudecz, F; Cantagrel, A; Serre, G; Nogueira, L Journal: Annals of the rheumatic diseases Issue: Volume 73:Issue 6(2014) Page Start: 1246 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. THU0152 Who are the patients with rheumatoid arthritis (RA) who are getting comorbidity screening procedures in accordance with guidelines? a study of 769 established ra patients. (15th June 2017) Authors: Gossec, L; Foissac, F; Soubrier, M; Fayet, F; Bardin, T; Beauvais, C; Chales, G; Chary-Valckenaere, I; Dernis, E; Euller-Ziegler, L; Flipo, R-M; Gaudin, P; Guis, S; Marhadour, T; Mariette, X; Mouterde, G; Pouplin, S; Richette, P; Ruyssen-Witrand, A; Schaeverbeke, T Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 258 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗